RNA, U6 small nuclear 1109, pseudogene (RNU6-1109P)

RNU6-1109P is a *pseudogene* derived from the RNA, U6 small nuclear family, which is a key member of the major spliceosomal snRNAs in eukaryotes. U6 snRNA itself forms an essential part of the spliceosome, catalyzing the removal of introns from nuclear pre-mRNA through precise post-transcriptional modifications and structural rearrangements[1][3]. Pseudogenes such as RNU6-1109P arise frequently in vertebrate genomes via retrotransposition mechanisms, specifically L1-mediated reverse transcription, resulting in sequence copies that lack the regulatory elements and context necessary for the production of functional RNA[4][5]. These pseudogenes typically retain high sequence homology with canonical genes, sometimes preserving terminal regions, but are generally non-functional and not transcribed at meaningful levels. Their characterization is primarily useful for studying genomic evolution and retrotransposon activity, rather than for therapeutic development or disease research[4][5][6]. While the primary U6 snRNA gene is critical for splicing and cell viability, pseudogene copies such as RNU6-1109P are remnants of retrotranspositional events and do not participate in canonical biological activities[4][5][6]. Pseudogenes have sometimes been misannotated or misinterpreted as genuine targets due to similarity in naming, but do not meet criteria as drug targets. Their presence in gene annotation databases is mostly of genomic, not therapeutic, significance[4][6].

Other names

RNU6-1109PRNA, U6 small nuclear 1109, pseudogeneU6 snRNA pseudogene 1109